| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/06/2006 | CN1827645A Lomefloxacin conjugate and its preparing method and use |
| 09/06/2006 | CN1827644A Pefloxacin couple and its preparing method and use |
| 09/06/2006 | CN1827603A Novel pyrazole analogs acting on cannabinoid receptors |
| 09/06/2006 | CN1273466C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 09/06/2006 | CN1273465C Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
| 09/06/2006 | CN1273464C Optically pure R-(+)- Omeprazole prepn process |
| 09/06/2006 | CN1273463C (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 09/06/2006 | CN1273451C Piperidine MCH antagonists and their use in treatment of obesity |
| 09/06/2006 | CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 09/05/2006 | USRE39265 Heteroarylpiperidines, and their use as antipsychotics and analgetics |
| 09/05/2006 | US7102024 Functional biopolymer modification reagents and uses thereof |
| 09/05/2006 | US7102015 Maleimide compounds in liquid form |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7102008 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme |
| 09/05/2006 | US7101898 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 09/05/2006 | US7101897 Farnesyl transferase inhibitors |
| 09/05/2006 | US7101896 Pharmaceutical compositions and methods for use |
| 09/05/2006 | US7101892 2-(4-benzenesulfonyl-4-methyl-pentyl)-5-phenyl-2-aza-bicyclo[2.2.1]heptane; useful for treating sleep disorder, depression, anxiety |
| 09/05/2006 | US7101885 1-(4-Bromo-phenyl)-3-[2-(4-methyl-piperazin-1-yl)-pyridin-3-yloxy]-pyrrolidin-2-one; antagonists of the serotonin 5HT1B receptor; treating depression |
| 09/05/2006 | US7101884 Tyrosine kinase inhibitors |
| 09/05/2006 | US7101883 Antiinflammatory agents, antiischemic agents, malaria, Crohn's disease, skin disorders |
| 09/05/2006 | US7101881 N-(4-Chlorophenylacetyl)-8-(4-methylpiperazinyl)-tetrahydroisoquinoline; treating anxiety, depression, dysthymia, major depressive disorder, migraine, post-traumatic stress disorder, avoidant personality disorder, borderline personality disorder, phobias |
| 09/05/2006 | US7101875 E.g., 4-(2-(1-Benzhydryl-2-(2-((benzylsulfonyl)amino)ethyl)-5-chloro-1H-indol-3 -yl)ethoxy)benzoic acid; inhibitors of phospholipase enzymes, esp. phospholipase A2; antiarthritic and -inflammatory agents; analgesics; rheumatoid diseases |
| 09/05/2006 | US7101871 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/05/2006 | US7101870 2R,3S) N1-[6,7-dihydro-5-(3-phenoxybenzyl)-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; treating Alzheimer's disease and Down's Syndrome by inhibiting production of A beta -peptide |
| 09/05/2006 | US7101869 2,4-diaminopyrimidine compounds useful as immunosuppressants |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 08/31/2006 | WO2006091702A2 Multimediator dopamine transport inhibitors, and uses related thereto |
| 08/31/2006 | WO2006091692A1 Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors |
| 08/31/2006 | WO2006091674A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 08/31/2006 | WO2006091592A1 Naphthalene derivatives as modulators of the glucocorticoid receptor |
| 08/31/2006 | WO2006091575A2 Method of increasing drug oral bioavailability and compositions of less toxic orotate salts |
| 08/31/2006 | WO2006091534A1 Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors |
| 08/31/2006 | WO2006091428A2 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity |
| 08/31/2006 | WO2006090920A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR ACTIVATING RECEPTOR δ |
| 08/31/2006 | WO2006090915A1 Pyridyl acetic acid compounds |
| 08/31/2006 | WO2006090853A1 Nitrogenous heterocyclic compound and medicinal use thereof |
| 08/31/2006 | WO2006090817A1 Indole compound and use thereof |
| 08/31/2006 | WO2006090743A1 1-(2h)-isoquinolone derivative |
| 08/31/2006 | WO2006090717A1 Quinazoline derivative having tyrosine kinase inhibitory activity |
| 08/31/2006 | WO2006090279A1 Oxyindole derivatives as 5ht4 receptor agonists |
| 08/31/2006 | WO2006090244A1 New adamantane derivatives as dipeptidyl, peptidase iv inhibitors, processes for their preparation, and pharmaceutical compositions containing them |
| 08/31/2006 | WO2006090235A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 08/31/2006 | WO2006090234A1 Heterocyclic derivatives as cell adhesion inhibitors |
| 08/31/2006 | WO2006090163A1 Quinazoline derivatives as tyrosine kinase inhibitors |
| 08/31/2006 | WO2006089798A1 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors |
| 08/31/2006 | WO2006089700A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists |
| 08/31/2006 | WO2006089664A2 Heterocyclylamide-substituted imidazoles |
| 08/31/2006 | WO2006074025B1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 08/31/2006 | WO2006072393A3 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 08/31/2006 | WO2006066924A3 Azole derivatives with antimuscarinic activity |
| 08/31/2006 | WO2006066896A3 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 08/31/2006 | WO2006066133A3 Histone deacetylase inhibitors |
| 08/31/2006 | WO2006035068A3 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 08/31/2006 | WO2006031610A3 Bicyclic anilide spirolactam cgrp receptor antagonists |
| 08/31/2006 | WO2006010969A8 New heterocyclic carboxylic acid amide derivatives |
| 08/31/2006 | WO2005035507A3 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| 08/31/2006 | WO2004087053A3 Dipeptidyl peptidase inhibitors |
| 08/31/2006 | US20060194961 cost efficiency; environmentally friendly |
| 08/31/2006 | US20060194865 G-lactam derivatives as prostaglandin agonists |
| 08/31/2006 | US20060194864 Indole derivatives |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194861 e.g. 1-(1-cyclohexyl-5-(4-(methylsulfonyl)phenyl)pyrazol-3-yl)-4-hydroxybutan-1-one; antiinflammatory agent, analgesic, antipyretic, wound healing agents; gastrointestinal disorders; side effect reduction |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194843 4-(2,6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide; anticancer agents; carcinoma of the colon; antifungal agents; antitumor agents; infections; 4-(2,6-difluoro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methyl-piperidin-4-yl)-amide |
| 08/31/2006 | US20060194841 Benzylamine derivative |
| 08/31/2006 | US20060194836 Novel compounds having 4-pyridylalkylthio group as substituent |
| 08/31/2006 | US20060194834 Serotonin receptor antagonist; psychological disorders; Alzheimer's disease |
| 08/31/2006 | US20060194824 Compositions containing pyrimidine derivatives as inhibitors of cox-2 |
| 08/31/2006 | US20060194822 Treatment for renal fibrosis |
| 08/31/2006 | US20060194818 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | US20060194811 Pyrimidine derivatives |
| 08/31/2006 | US20060194807 Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 08/31/2006 | US20060194805 Capsaicin receptor agonists |
| 08/31/2006 | US20060194803 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder |
| 08/31/2006 | US20060194798 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 08/31/2006 | US20060194795 Platelet ADP receptor inhibitors |
| 08/31/2006 | US20060194794 oxadiazoles such as 2-({[5-(3,4,5,6-Tetrahydro-2H-[1,2']bipyridinyl-4-yl)-[1,3,4]oxadiazol-2-ylmethyl]-amino}-methyl)-phenylamine exhibiting vasopressin antagonistic activity and can be used in the treatment of dysmenorrhea |
| 08/31/2006 | US20060194793 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194792 1-Cyclic carbonyl-4-(4-quinoline-)-1,4-diazepine or 1-cyclic carbonyl-4-[4-(1H-quinolin-2-{thio}one)-1,4-diazepinone derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 08/31/2006 | US20060194787 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 08/31/2006 | US20060194786 Process and intermediates for preparing benzazepines |
| 08/31/2006 | US20060194783 Cgrp receptor antagonists |
| 08/31/2006 | US20060194778 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 08/31/2006 | US20060194772 Triamide-substituted heterobicyclic compounds |
| 08/31/2006 | US20060194073 Organic compound and organic electrolumiscent device |
| 08/31/2006 | US20060193926 To treat psychiatric and mood disorders, pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, drug addiction, drug abuse, drug withdrawal, obesity; 2-[1-(3-methoxy-4-pyridin-2-ylphenyl)-1H-pyrrol-3-yl]pyridine; minimal side effects |
| 08/31/2006 | US20060193780 cyanine dyes and/or with lipophilic side chains; to detect stained cells both in vivo and in vitro; increased signal to noise ratio for rapidly labeling; improved solubility |
| 08/31/2006 | DE102005008183A1 New heterocyclylamide-substituted imidazole compounds useful to treat or prevent viral infections |
| 08/31/2006 | CA2614731A1 Multimediator dopamine transport inhibitors, and uses related thereto |
| 08/31/2006 | CA2602379A1 Method of increasing drug oral bioavailability and compositions of less toxic orotate salts |
| 08/31/2006 | CA2599454A1 Activator for peroxisome proliferator activating receptor d |
| 08/31/2006 | CA2599449A1 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors |
| 08/31/2006 | CA2599348A1 Indole compound and use thereof |
| 08/31/2006 | CA2599210A1 Quinazoline derivatives as tyrosine kinase inhibitors |
| 08/31/2006 | CA2598934A1 Pyridyl acetic acid compounds |
| 08/31/2006 | CA2598853A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists |
| 08/31/2006 | CA2598651A1 Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors |
| 08/31/2006 | CA2598568A1 Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors |